Europe’s cannabis economy has long been described as a sleeping giant. A new international report suggests that the European sleeping giant may finally be waking up.

Released during this week’s Cannabis Europa 2026 conference in London, a new report from the Global Cannabis Network Collective (GCNC), produced in partnership with Whitney Economics, examines how medical cannabis expansion, international trade, pharmaceutical manufacturing standards, and evolving regulatory frameworks are transforming the EU and UK into one of the most closely watched regions in the global cannabis industry.

The report, What You Need to Know: EU & UK Cannabis Market Update, combines quantitative analysis from Whitney Economics with perspectives from operators, attorneys, consultants, patient advocates, and market leaders across Europe and the United Kingdom.

The findings suggest the European cannabis market is entering a critical transition period as medical access programs expand, telemedicine accelerates patient adoption, EU GMP standards reshape supply chains, and countries across the region continue developing distinct regulatory frameworks.

“Europe is taking a far more methodical and medically oriented approach to cannabis reform than many markets pursued during earlier expansion cycles,” said Beau Whitney, Chief Economist of Whitney Economics and lead author of the report. “That slower pace may frustrate some operators, but it is also creating a level of structure, predictability, and long-term institutional credibility that is attracting increasing international attention.”

According to the report, Europe ranks as the second-largest cannabis total addressable market globally by value, despite remaining fragmented across numerous national regulatory systems. At the same time, medical access programs, telemedicine platforms, and international supply chains are rapidly evolving across the region.

Among the report’s findings:

• Germany continues to set the pace for cannabis reform in Europe, though mounting imports and pricing pressure are beginning to reshape market economics.
• The UK medical cannabis market is expanding rapidly through private clinics and telemedicine, despite ongoing barriers tied to physician education, affordability, stigma and NHS participation.
• International cannabis trade into Europe continues accelerating, with imports flowing from Canada, Portugal, Latin America, Africa, Australia, and other emerging supply regions.
• EU GMP standards are increasingly becoming a defining factor for companies seeking long-term participation in European medical cannabis markets.
• Industry observers estimate the next three to five years will be a defining period for both policy reform and market growth across Europe and the UK.

“Europe is no longer simply reacting to cannabis reform,” said Jillian Reddish, co-founder of GCNC. “The region is increasingly helping shape what the next phase of the global cannabis industry looks like, from international trade standards and medical access models to pharmaceutical manufacturing expectations and long-term market infrastructure.”

The report includes regional market insights and commentary from contributors across Germany, Portugal, Spain, Czechia, and the United Kingdom, highlighting both the opportunities and operational complexities emerging throughout the region. Topics include Germany’s rapidly evolving telemedicine ecosystem, Portugal’s growing role as a cultivation and processing hub, Spain’s medical access reforms, and the Czech Republic’s nascent and evolving cannabis policies.

The report also notes that pricing compression, already visible across mature cannabis markets globally, is beginning to emerge in Europe as imports increase, supply chains mature, and competitive pressures intensify. Germany, in particular, is showing early signs of wholesale and retail pricing declines tied to expanding imports and inventory growth.

For operators, investors, and policymakers, the report emphasizes the importance of understanding market share, regulatory risk, supply-demand dynamics, and long-term positioning as Europe’s cannabis economy continues evolving.

For years, cannabis has often been framed through the lens of disruption and limitless upside. But as international markets mature, the report suggests the industry is increasingly being shaped by the same forces influencing other global commodities: trade routes, logistics, manufacturing standards, supply economics, and price competition. As markets evolve, long-term success will depend not only on demand, but on operational efficiency, regulatory compliance, and the ability to compete within an increasingly interconnected global marketplace.

Download the Report: The full report, What You Need to Know: EU & UK Cannabis Market Update, is available at this link.

For more information or to schedule an interview, please contact Shawna Seldon at 1-917-971-7852 or Email Contact.

About GCNC

The Global Cannabis Network Collective (GCNC) is a membership-based organization connecting cannabis operators, investors, and service providers worldwide. GCNC facilitates strategic connections, market intelligence, and drives international deal flow across the global cannabis supply chain. For more information, visit GCNC.Global. Continue the conversation on LinkedIn.

About Whitney Economics

Portland, Oregon-based Whitney Economics is a global leader in cannabis and hemp business consulting, data, and economic research, supporting hemp and cannabis operators, investors and regulators. Whitney Economics does not take a position on the legalization of cannabis, nor does it take positions on proposed legislation. Visit WhitneyEconomics.com.

This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform™. Reference URL for this press release is here.

As cannabis markets expand across Europe, Latin America, and other emerging regions, a new global report from the Global Cannabis Network Collective (GCNC), produced in partnership with Whitney Economics, introduces pricing compression as one of the clearest indicators of cannabis market maturity and one of the most misunderstood risks facing operators, investors, and policymakers today.

The report, What You Need to Know: Pricing Compression and Its Impact on International Cannabis Markets, combines quantitative analysis from Whitney Economics with qualitative insight from operators, economists, legal experts, and market leaders across North America, Europe, Latin America, and Israel.

The findings show that while new cannabis markets often launch with elevated pricing and strong growth expectations, many eventually experience sustained downward pricing pressure as supply expands, regulations evolve, and markets mature.

“Every cannabis market evolves differently, but the pricing patterns are remarkably consistent,” said Beau Whitney, Economist, Whitney Economics. “The operators and investors that perform best are typically the ones using data to anticipate where the market is heading, rather than reacting after margins are already under pressure.”

The report examines how pricing compression has developed across mature U.S. markets, Canada, and Germany, while also analyzing emerging trends across Europe and Latin America. The report examines how regulatory frameworks, supply constraints, imports, consumer behavior, and reimbursement structures directly influence pricing stability and operator profitability.

Germany, widely viewed as Europe’s anchor cannabis market, is already showing early signs of accelerated pricing pressure tied to import growth and shifting regulatory structures.

“Germany is one of the clearest examples of how regulation can directly reshape market pricing,” said Aleksandra Vujinović, Founder, Attorney at Law & Strategic Legal Architect, AV LEGAL. “As reimbursement structures and access pathways evolved, the market shifted quickly from scarcity-driven pricing to competitive pricing pressure. That transition impacted supply chains, operational planning, and long-term positioning almost immediately.”

The report argues that pricing compression is not necessarily a sign of market failure, but rather a predictable phase of market development that can be modeled, monitored, and strategically planned for.

“The cannabis industry is moving from isolated markets to a truly global ecosystem, but operators are still navigating vastly different regulatory and commercial realities,” said Jillian Reddish, Co-founder, GCNC. “This report is designed to provide a clearer line of sight into how markets evolve, where pricing pressure is emerging, and what operators should be watching before making expansion decisions.”

The report also examines how increasingly competitive markets are reshaping global supply chains and influencing the next generation of export opportunities.

“Across global markets, we are seeing a clear shift as patients and consumers increasingly seek out trusted, consistent, high-quality products as they move toward more premium choices,” said Margaret Brodie, CEO, Rubicon Organics. “Operators who have built their businesses around delivering reliable quality and elevated experiences are well positioned to support the continued maturation of international markets.”

Additional report topics include:

• The relationship between regulation and pricing stability
• Differences between medical and adult-use pricing behavior
• Consumer price sensitivity and legal market participation
• Supply saturation and margin compression
• Predictive pricing models for emerging cannabis markets
• Strategic considerations for operators, investors, and policymakers

The report is the first in a planned global series examining cannabis market development across Europe, Latin America, Africa, and other emerging regions.

What You Need to Know: Pricing Compression and Its Impact on International Cannabis Markets is now available at this link.

For more information or to schedule an interview, please contact Shawna Seldon at 1-917-971-7852 or Email Contact.

About GCNC

The Global Cannabis Network Collective (GCNC) is a membership-based organization connecting cannabis operators, investors, and service providers worldwide. GCNC facilitates strategic connections, market intelligence, and drives international deal flow across the global cannabis supply chain. For more information, visit GCNC.Global. Continue the conversation on LinkedIn.

About Whitney Economics

Portland, Oregon-based Whitney Economics is a global leader in cannabis and hemp business consulting, data, and economic research, supporting hemp and cannabis operators, investors and regulators. Whitney Economics does not take a position on the legalization of cannabis, nor does it take positions on proposed legislation. Visit WhitneyEconomics.com.

This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform™. Reference URL for this press release is here.